Retrospective study examines biochemical remission factors in acromegaly post transsphenoidal surgery, highlighting key serum levels.
Background/Introduction This study aimed to determine the factors predicting postoperative biochemical remission in patients with acromegaly who underwent transsphenoidal surgery. Methods This single-center retrospective study included patients diagnosed with treatment-naive acromegaly. Preoperative and early postoperative days (postoperative days 2-4) serum levels of growth hormone (GH), insulin-like growth factor 1 (IGF-1), IGF-1 standardized to the upper limit of normal (IGF-1 ULN), calcium and phosphorus were obtained from hospital records. Patients were divided into two groups according to their biochemical remission status within 3-6 months after transsphenoidal surgery. Results Of the 68 patients who underwent surgery, 44 (64.7%) achieved biochemical remission. Preoperative GH, IGF-1, and IGF-1 ULN levels were significantly higher in the non-remission group compared to those who achieved remission (p<0.005). Although preoperative calcium levels were significantly different between groups (p=0.006), phosphorus levels were not (p=0.248). GH, IGF-1, IGF-1 ULN, calcium, and phosphorus levels measured in the early postoperative days were significantly lower in the remission group (all p < 0.05). GH level in the early postoperative days was significantly correlated with IGF-1 (p < 0.001), IGF-1 ULN (p < 0.001) and phosphorus (p < 0.05). IGF-1 ULN was also correlated with early postoperative calcium (p < 0.05) and phosphorus levels (p <0.05). Conclusion(s) Monitoring IGF-1, GH, calcium, and phosphorus levels in the early postoperative period may contribute to the evaluation of biochemical remission in patients with acromegaly.
No takes yet. Share an insight, caveat, or question.
Babayeva et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: